دورية أكاديمية
أعرض في EDS

Polypharmacy among older Brazilians: prevalence, factors associated, and sociodemographic disparities (ELSI-Brazil).

التفاصيل البيبلوغرافية
العنوان: Polypharmacy among older Brazilians: prevalence, factors associated, and sociodemographic disparities (ELSI-Brazil).
المؤلفون: Seixas BV; BPharm, MSc. Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Los Angeles, CA (United States). brayanseixas@ucla.edu., Freitas GR; BPharm, MSc, PhD. Graduate Program of Public Health, Department of Pharmaceutical Sciences, Federal University of Paraíba. João Pessoa (Brazil). gabriel.freitas@academico.ufpb.br.
المصدر: Pharmacy practice [Pharm Pract (Granada)] 2021 Jan-Mar; Vol. 19 (1), pp. 2168. Date of Electronic Publication: 2021 Jan 22.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Centro de Investigaciones y Publicaciones Farmaceuticas Country of Publication: Spain NLM ID: 101530029 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1885-642X (Print) Linking ISSN: 1885642X NLM ISO Abbreviation: Pharm Pract (Granada) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: <2012>-: Redondela : Centro de Investigaciones y Publicaciones Farmaceuticas
Original Publication: Granada : Grupo de Investigación en Atención Farmacéutica
مستخلص: Background: Polypharmacy has become an increasingly public health issue as population age and novel drugs are developed. Yet, evidence on low- and middle-income countries (LMIC) is still scarce.
Objective: This work aims to estimate the prevalence of polypharmacy among Brazilians aged 50 and over, and investigate associated factors.
Methods: A cross-sectional study was conducted using data from the baseline assessment of the Brazilian Longitudinal Study of Aging (ELSI-Brazil), a nationally representative study of persons aged 50 years and older (n=9,412). Univariate and bivariate analyses described the sample. Robust Poisson regression was used to estimate prevalence ratios and predict probabilities of polypharmacy.
Results: Prevalence of polypharmacy was estimated at 13.5% among older adults in Brazil. Important disparities were observed in regard to gender (16.1% among women and 10.5% among men), race (16.0% among whites and 10.1% among blacks) and geographic region (ranging from 5.1% in the North to 18.7% in the South). The multivariate analysis showed that polypharmacy is associated with various sociodemographic/individual factors (age, gender, race, education, region, health status, body mass index) as well as with several variables of healthcare access/utilization (number of visits, same physician, provider's knowledge of patient's medications, gate-keeper, and difficulty managing own medication). Overall, the more utilization of health services, the higher the probability of polypharmacy, after adjusting for all other model covariates.
Conclusions: Polypharmacy prevalence is relatively low in Brazil, compared to European countries. After controlling for variables of healthcare need and demographic characteristics, there is still substantial residual variance in polypharmacy prevalence. Policies to identify inappropriate prescribing and reduce regional discrepancies are necessary.
Competing Interests: CONFLICT OF INTEREST The authors declare no conflict of interest.
(Copyright: © Pharmacy Practice and the Authors.)
References: Cochrane Database Syst Rev. 2018 Sep 03;9:CD008165. (PMID: 30175841)
Aging Med (Milton). 2018 Dec;1(3):254-266. (PMID: 31410389)
DICP. 1990 Mar;24(3):321-3. (PMID: 2316239)
BMC Health Serv Res. 2016 Nov 16;16(1):661. (PMID: 27852287)
Pharm Pract (Granada). 2014 Jul;12(3):420. (PMID: 25243030)
Cochrane Database Syst Rev. 2002;(2):CD000011. (PMID: 12076376)
Drug Saf. 2016 Feb;39(2):109-16. (PMID: 26692396)
Rev Panam Salud Publica. 2008 Jan;23(1):34-43. (PMID: 18291071)
Arch Public Health. 2015 Nov 09;73:50. (PMID: 26557365)
BMC Geriatr. 2017 Oct 10;17(1):230. (PMID: 29017448)
BMJ Open. 2018 Mar 14;8(3):e020270. (PMID: 29540422)
BMJ Open. 2016 Apr 04;6(4):e010505. (PMID: 27044582)
Eur J Clin Pharmacol. 2017 Nov;73(11):1475-1489. (PMID: 28779460)
Fam Pract. 2007 Feb;24(1):14-9. (PMID: 17164234)
Curr Aging Sci. 2019;12(2):121-154. (PMID: 31096900)
Clin Geriatr Med. 1992 Feb;8(1):143-58. (PMID: 1576572)
Arch Gerontol Geriatr. 2018 Sep - Oct;78:213-220. (PMID: 30015057)
Pharm Pract (Granada). 2020 Oct-Dec;18(4):2133. (PMID: 33149794)
Cad Saude Publica. 2012 Jan;28(1):104-14. (PMID: 22267070)
Br J Clin Pharmacol. 2018 Jul;84(7):1432-1444. (PMID: 29575094)
Age Ageing. 2013 Jan;42(1):62-9. (PMID: 22910303)
Pharm Pract (Granada). 2016 Apr-Jun;14(2):706. (PMID: 27382425)
Eur J Clin Pharmacol. 2017 Sep;73(9):1165-1172. (PMID: 28601963)
Stat Methods Med Res. 2010 Dec;19(6):653-70. (PMID: 19654173)
BMJ. 2009 Jun 29;338:b2393. (PMID: 19564179)
Br J Clin Pharmacol. 2015 Oct;80(4):796-807. (PMID: 25619317)
J Clin Pharm Ther. 2019 Jun;44(3):349-360. (PMID: 30746726)
Intern Emerg Med. 2017 Mar;12(2):213-220. (PMID: 27075646)
Value Health. 2019 Feb;22(2):139-156. (PMID: 30711058)
J Midlife Health. 2018 Apr-Jun;9(2):97-103. (PMID: 29962809)
Arch Gerontol Geriatr. 2017 Jan - Feb;68:55-61. (PMID: 27649514)
Am J Epidemiol. 2018 Jul 1;187(7):1345-1353. (PMID: 29394304)
فهرسة مساهمة: Keywords: Age Factors; Brazil; Cross-Sectional Studies; Health Services Accessibility; Multimorbidity; Multivariate Analysis; Polypharmacy; Prevalence; Race Factors; Sex Factors; Socioeconomic Factors
تواريخ الأحداث: Date Created: 20210201 Latest Revision: 20220420
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7844972
DOI: 10.18549/PharmPract.2021.1.2168
PMID: 33520038
قاعدة البيانات: MEDLINE
الوصف
تدمد:1885-642X
DOI:10.18549/PharmPract.2021.1.2168